Yellow Fever Vaccine Market By Type of Vaccine (Live Attenuated Vaccine, Inactivated Vaccine, Recombinant Vaccine), By Application (Prevention of Yellow Fever, Travel Vaccination, Outbreak Control, Prevention of Yellow Fever in Special Populations), By Distribution Channel (Direct Sales, Government Procurement, Online Pharmacies, Retail Pharmacies, Wholesale Distribution), By End User (Hospitals, Clinics, Public Health Organizations, Travel Health Centers, Pharmacies, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Report Coverage:

By Type of Vaccine

• Live Attenuated Vaccine
• Inactivated Vaccine
• Recombinant Vaccine

By Application

• Prevention of Yellow Fever
• Travel Vaccination
• Outbreak Control
• Others

By Distribution Channel

• Direct Sales
• Government Procurement
• Online Pharmacies
• Retail Pharmacies
• Wholesale Distribution

By End User

• Hospitals
• Clinics
• Public Health Organizations
• Travel Health Centers
• Pharmacies
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Sanofi Pasteur
• Bio-Manguinhos
• FSUE Chumakov
• Institut Pasteur de Dakar
• iBio, Inc.
• GlaxoSmithKline PLC
• Merck & Co., Inc.
• Biological E Limited
• Panacea Biotec
• Takeda Pharmaceutical Company Ltd
• Valneva SE
• Bavarian Nordic
• Hualan Biological Engineering Inc.
• Wockhardt Ltd.
• AbbVie Inc.
• Serum Institute of India Pvt. Ltd.
• CureVac AG